Comparative Structural Analysis of Biarylphosphine Ligands in Arylpalladium Bromide and Malonate Complexes by Goutierre, Anne-Sophie et al.
Comparative Structural Analysis of Biarylphosphine Ligands in Arylpal-
ladium Bromide and Malonate Complexes 
Anne-Sophie Goutierre,† Huu Vinh Trinh,† Paolo Larini,† Rodolphe Jazzar,† and Olivier Baudoin*,†,‡ 
†Université Claude Bernard Lyon 1, CNRS UMR 5246 - Institut de Chimie et Biochimie Moléculaires et Supramoléculaires, 
CPE Lyon, 43 Boulevard du 11 Novembre 1918, 69622 Villeurbanne, France. 
‡Current address: Department of Chemistry, University of Basel, St. Johanns-Ring 19, CH-4056 Basel, Switzerland. 
Supporting Information Placeholder
ABSTRACT: The substitution of biarylphosphine lig-
ands was shown to have a marked impact on the a/b 
selectivity of the arylation of ester enolates. To get fur-
ther insight into this effect, the solid-state structures of 
arylpalladium bromide and malonate complexes with 
four different biarylphosphine ligands were obtained by 
X-ray diffraction analysis. Structural differences were 
not very pronounced except for the conformationally 
restricted CPhos ligand, which showed a bidentate coor-
dination mode in the oxidative addition complex, where-
as the other ligands form dimeric species. 
INTRODUCTION 
The achievement of catalyst-controlled site-selectivity in 
catalytic transformations is a topic of increasing inter-
est.1 However, the rational design of selective catalysts 
is often hampered by a lack of precise information on 
substrate-catalyst interactions during the selectivity-
determining step(s). We have recently developed a Pd-
catalyzed migrative arylation of ester enolates2a-c and 
silyl ketene acetals,2d which allows to functionalize re-
mote C–H bonds of linear alkyl chains of esters. In this 
process, the arylation selectivity was shown to be both 
ligand- and substrate-controlled (Scheme 1). In particu-
lar, by testing a number of analogous biarylphosphine 
ligands on the arylation of isobutyric ester enolates (R1 = 
Me), we found that the substitution pattern of the former 
had a great influence on the arylation selectivity.2b Pre-
vious studies from Barder and Buchwald demonstrated 
the effect of binding modes and conformations of biar-
ylphosphine ligands on elementary steps of various 
cross-coupling reactions.3 Such effects are likely to op-
erate as well in migrative cross-coupling reactions, 
hence a better understanding thereof should have im-
portant implications for the development of new vari-
ants.4-5 Herein, we describe a structural study of model 
biarylphosphine–arylpalladium bromide and malonate 
complexes, which represents a first step toward this 
goal. 
Scheme 1. a- vs. b-Arylation of Ester Enolates 
 
RESULTS AND DISCUSSION 
Catalytic reactions with representative biar-
ylphosphines. The effect of four representative biar-
ylphosphine ligands on the selectivity of the arylation of 
the lithium enolate of tert-butylisobutyrate 1 with two 
different aryl bromides is shown in Table 1. With m-
fluorobromobenzene 2a as the electrophile, ligand L1 
(DavePhos)6 furnished an a/b (3a/4a) ratio of 47:53, in 
line with previous results (entry 1).2a-b A similar ratio 
was obtained with second generation imidazole-based 
ligand L2 (entry 2).2c-d Ligand L3,7 which is isosteric to 
L1, significantly altered the a/b ratio in favor of a-
arylated product 3a (entry 3). CPhos L4, bearing two 
NMe2 groups on the non-phosphine-containing ring,8 
had a dramatic effect on the selectivity, with 3a being 
exclusively obtained (entry 4). This is consistent with 
the fact that this ligand was developed to avoid Pd mi-
gration in Negishi-type cross-couplings. The same over-
all trend was observed with aryl bromide 2b bearing two 
strong electron-withdrawing CF3 groups at the meta 
positions (entries 5-8). Indeed, ligands L1-L2 bearing 
only one NMe2 group mainly gave b-arylated product 4b 
(entries 5-6), whereas ligand L4 gave 3b as the major 
product (entry 8), and ligand L3 was somewhat in be-
tween (entry 7). However, the impact of the ligand on 
the arylation selectivity was less pronounced for aryl 
bromide 2b compared to 2a, in line with previous re-
sults. This is due to a higher degree of substrate-
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controlled selectivity for aryl bromide 2b containing two 
strongly electron-withdrawing CF3 groups. Hence, the 
nature and number of ortho substituents on the non-
phosphine-containing ring of  ligands L1-L4 have a 
marked effect on the arylation selectivity, thereby point-
ing to the influence of electronic and/or conformational 
factors within the Pd intermediates during the reaction. 
To further investigate these effects, ligands L1-L4 were 
chosen for the preparation and study of arylpalladium 
bromide and malonate complexes. 
Table 1. Effect of Representative Biarylphosphine Ligands 
on the a/b Selectivity of the Arylation of Ester Enolatesa 
 
Entry ArBr Ligand a/b ratiob 
1 2a L1 47:53 
2 2a L2 49:51 
3 2a L3 65:35 
4 2a L4 >99:1 
5 2b L1 15:85 
6 2b L2 17:83 
7 2b L3 27:73 
8 2b L4 85:15 
 
a Reaction conditions: 1 (1.6 equiv), Cy2NLi (1.7 equiv), 
aryl bromide (1 equiv), Pd2dba3 (5 mol%), ligand (10 
mol%), toluene, 50 °C. b Determined by 19F NMR. 
Synthesis and characterization of oxidative addition 
complexes containing ligands L1-L4. Palladium com-
plexes A1-A4 were prepared in one step by addition of 
2b to a 1:1 mixture of the appropriate ligand and 
(COD)Pd(CH2SiMe3)2 in THF at 20 °C, and they were 
isolated as pure solids in reasonable yields (48-86%). 
Aryl bromide 2b was chosen after initial investigations 
with 2a due to a higher stability of the corresponding 
bromide and malonate complexes (vide infra). Indeed, 
the strong electron-withdrawing CF3 substituents in 2b 
should stabilize the corresponding aryl–palladium com-
plexes by strengthening the CAr–Pd bond.2b,9 Suitable 
monocrystals of A1-A3 were readily obtained from a 
CDCl3/hexane mixture, and the corresponding X-ray 
structures are shown in Figure 1. In the solid state, com-
plexes A1-A3 display a bromo-bridged dimeric structure 
(A1dim-A3dim), with A1dim having a bent character be-
tween the two palladium units along the Br–Br axis 
(137.2o), presumably to minimize steric repulsions be-
tween the respective L1 ligands. In all structures the sum 
of the angles around the palladium center ranging be-
tween 359.6°-361.7° demonstrates planarity at the metal 
with only minor distortions. In contrast, the X-ray crys-
tallographic analysis of complex A4 revealed a mono-
meric species featuring an interaction between the palla-
dium center and the biphenyl ipso carbon (C16). The 
presence of this type of Pd–Cipso bond in palladium(II)-
biarylphosphine oxidative addition complexes has been 
previously reported with CPhos L4 as the ligand8b and in 
structurally related BrettPhos-type ligands bearing i-Pr 
instead of NMe2 groups.10 The Pd–Cipso bond length of 
2.467(3) Å in A4 lies in the range of distances reported 
in these CPhos (2.478 Å) and BrettPhos-based complex-
es (2.439-2.527 Å). As expected, the Pd–Cipso interaction 
causes a pyramidalization at C16 and an elongation of the 
C16–C17 and C16–C24 aromatic bonds to 1.431(4) and 
1.442(4) Å, respectively. In addition, the C24–N25 bond is 
significantly shorter (1.383(4) Å) than the other ortho 
C17–N18 bond (1.432(4) Å) and N25 is less pyramidalized 
than N18 (sum of the bond angles at N25 and N18: 355.0 
and 338.6°, respectively), thereby indicating a non-
symmetrical participation of these nitrogen atoms to the 
bonding interaction with Pd.11 In contrast to A4, com-
plexes A1dim-A3dim  do not show any real bonding inter-
action between Pd and the non-phosphine-containing 
ring of the ligand in the solid state. Indeed, the Pd atom 
shows no pyramidalization in A1dim-A3dim, with its coor-
dination sphere being completed by the µ-bromo ligand, 
and the shortest distance between Pd and the non-
phosphine-containing ring ranges from 3.06 (A3dim) to 
3.42  Å (A1dim) (Figure 1). In addition, the ortho NMe2 
or i-Pr group in A2dim-A3dim is pointing away from the 
metal, whereas the NMe2 group is pointing toward Pd in 
A1dim. It should be also noted that imidazole-based lig-
and L2 does not exhibit coordination of Pd by the imid-
azole nitrogen atom, in contrast to a previous X-ray 
structure with an analogous ligand.12  
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Thus, the above structures highlight a significant bond-
ing behavior between ligands L1-L3 and L4. In solution 
in CDCl3 at 20 °C, complex A1 mainly occurs as the 
bromo-bridged dimer A1dim, as indicated by the presence 
of a sharp singlet resonating at 29.8 ppm in 31P{1H} 
NMR (see the Supporting Information). How-
ever, in C6D6, i. e. in a solvent that has closer 
properties to the actual solvent employed in 
catalysis (toluene), the 31P{1H} NMR spec-
trum of A1 shows a broad signal resonating at 
54 ppm, characteristic of a monomeric species. 
This observation is in accordance with NMR 
studies by Buchwald, Barder and co-workers.3c 
Similarly, 31P{1H} NMR analyses indicate that 
complexes A2-A3 occur as monomeric species 
in C6D6 and as mixtures of monomer and bro-
mo-bridged dimer in CDCl3. In contrast, com-
plex A4 occurs as a single monomeric species 
in CDCl3, in agreement with previous data.8b  
However, its 31P{1H} NMR spectrum in C6D6 
shows two signals ascribed to two different 
monomeric species.3c Unfortunately, we were 
unable to obtain additional information from 
NMR data due to the fluxional behavior of the 
above complexes, even by performing variable 
temperature experiments.  
Synthesis and characterization of malonate 
complexes containing ligands L1-L4. On the 
basis of DFT calculations, we previously pro-
posed that a-arylated products (3a-b, Table 1) 
arise from the reductive elimination of O-
bound Pd enolate C (Scheme 1).2b On the other 
hand, the equilibration of C to b-agostic com-
plex D opens up the b-arylation pathway, 
which proceeds through b-hydride elimination, 
rotation, insertion and reductive elimination.2b 
Culkin and Hartwig showed that the stability 
of arylpalladium enolate-diphosphine com-
plexes is inversely proportional to the substitu-
tion at the a carbon.13 In accordance with 
these results, we were unable to isolate Pd 
enolates from the reaction of the potassium 
enolate of 1 with oxidative addition complexes 
ArPdLBr (L = biarylphosphine). As a conse-
quence, we turned our attention to malonate 
complexes, as more stable surrogates of Pd 
enolates C-D.14 We initially attempted to pre-
pare such a complex from the oxidative addi-
tion complex, obtained from DavePhos L1 and 
1-bromo-2-fluorobenzene, that we previously 
reported.2b Unfortunately in this case, we were 
not able to isolate the malonate complex, and 
observed the formation of the a-arylated prod-
uct. Although it proved difficult to prepare 
malonate complexes that were sufficiently 
stable to be isolated and crystallized, we found 
that the presence of the two electron-withdrawing CF3 
groups on the aryl ligand provided the required stability. 
Metathetical exchange between the potassium salt of 
dimethyl malonate (5a) and the bromide ligand in com-
 
Figure 1. X-ray crystal structures of oxidative addition complexes A1-A4 
showing selected distances (ellipsoids at 50% probability, H atoms omitted 
for clarity). 
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plexes A1-A3 readily occurred in THF at 0 °C to generate 
the k2-O,O’-bound palladium dimethyl malonate com-
plexes B1-B3 which could be fully characterized. The X-
ray crystal structures of B1-B3 are shown in Figure 2. No 
unusual angles at the palladium center were found in B1-
B3. As expected, the Pd–O1 bonds trans to the aryl lig-
and are longer than the Pd–O2 bonds trans to the phos-
phine ligand (2.107(3) Å vs. 2.091(1) Å for B1; 2.115(1) 
Å vs. 2.094(1) Å for B2; 2.115(2) Å vs. 2.095(2) Å 
for B3). The spatial orientations of the biaryl moie-
ties of the phosphine ligands observed in A1dim-A3dim 
are preserved in B1 and B3, but a rotation of the non-
phosphine-containing ring of the ligand is observed 
in B2, thus placing the nitrogen atom of the NMe2 
moiety at the pseudo-apical position of the Pd center, 
similar to B1. The shortest distances between this 
aromatic ring and Pd in B1-B3 ranges from 3.12 to 
3.27 Å, with no significant pyramidalization at the 
Pd center, and thus with no particular bonding char-
acter, similar to the corresponding oxidative addition 
complexes A1dim-A3dim.  
Finally, malonate complex B4 was readily obtained 
from complex A4 under the same reaction conditions 
(Scheme 2). However, when B4 was left to crystal-
lize at 5 °C in a C6D6/hexane mixture, we were sur-
prised to obtain the crystal structure of the parent 
complex B4’ bearing the arylated malonate. Complex 
B4’ displays the same k2-O,O’-coordination mode 
and overall structure as complexes B1-B3 (Figure 2, 
bottom right). It is probably formed by displacement 
of the malonate ligand in B4 by the in situ-formed 
arylated malonate anion 5b, arising from reductive 
elimination of the putative C-enolate B4''. In addi-
tion, B4’ could be obtained directly from A4 and 
malonate anion 5b in a separate experiment. DFT 
modeling of the isodesmic reaction between B4 and 
B4’ showed that the formation of B4’ is thermody-
namically favored by 4.6 kcal mol–1, which accounts 
for the isolation of B4’ rather than B4. 
Discussion. The above results show that CPhos L4 
behaves differently from the other studied ligands in 
both oxidative addition, where it adopts a bidentate 
binding mode, and malonate, where it seems to favor 
reductive elimination, complexes. This behavior can 
be inferred to the reduced conformational freedom at 
the biaryl bond of L4 compared to L1-L3, which 
should lower the energy barrier of C–C reductive 
elimination by virtue of steric decompression.13-14 
This property allows to explain the high a-
selectivity selectivity in the arylation of t-butyl iso-
butyrate 1 with this ligand (Table 1). Indeed, the two 
selectivity-determining steps were shown to be the 
a-reductive elimination and the olefin insertion with 
DavePhos L1 as the ligand.2b With a more rigid lig-
and such as CPhos L4, a-reductive elimination 
should become energetically more favorable and Pd 
migration less favorable, thereby favoring the a-arylated 
product (3a-b). Nevertheless, other factors must be in-
volved, as shown with the selectivity differences ob-
served among ligands L1-L3, which form structurally 
similar oxidative addition and malonate complexes. In 
particular, the hemilabile character of NMe2-containing 
ligands L1-L2 seems to be an important parameter in 
 
Figure 2. X-ray crystal structures of malonate complexes B1-B3 and 
B4’ showing selected distances (ellipsoids at 50% probability, H 
atoms omitted for clarity). 
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comparison with L3, which is isosteric but lacks the 
nitrogen coordinating group. The current study does not 
allow to decipher this more subtle effect, and further 
investigations with more dynamic reaction models3 will 
be conducted in the future to address this challenging 
issue. 
CONCLUSION 
This study represents a first step toward the understand-
ing of the origins of the ligand-induced selectivity in the 
normal (a) vs. migrative (b) arylation of ester enolates. 
The solid-state structures of two types of arylpalladium 
complexes, i. e. oxidative addition and malonate, were 
solved with four representative biarylphosphine ligands. 
These data highlight the influence of the ligand rigidity, 
with CPhos (L4) showing higher bidentate character and 
rigidity compared to ligands L1-L3 bearing only one 
ortho substituent on the non-phosphine containing ben-
zene ring. This rigidity (or conversely, flexibility) is 
likely a key factor in the control of the arylation selectiv-
ity.  
EXPERIMENTAL SECTION 
General Considerations. Reactions were performed under 
an atmosphere of argon with rigorous exclusion of moisture 
from reagents and glassware using standard techniques. 
Commercially available reagents were used without further 
purification unless otherwise stated. All bases, phosphines 
and palladium sources were stored in a glove box. Anhy-
drous solvents were obtained by distillation over calcium 
hydride (n-hexane) or sodium / benzophenone (THF, tolu-
ene). IR spectra were recorded on an FTIR spectrometer 
and data are reported in reciprocal centimeters (cm-1). 
NMR spectra (1H, 13C, 19F and 31P) were recorded on a 300, 
400 or 500 spectrometer in CDCl3 (residual peaks 1H δ 
7.26, 13C δ 77.16) or C6D6 (residual peaks 1H δ 7.16, 13C δ 
128.06). Chemical shifts are reported relative to the chemi-
cal shift of the residual solvent for 1H and 13C NMR. 19F 
NMR and 31P NMR spectra are calibrated with an external 
reference (CFCl3, δ 0.0, and H3PO4, δ 0.0, respectively) and 
recorded with complete proton decoupling. 
Data are reported as follows: chemical shift 
in parts per million (ppm), multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, 
m = multiplet, and br = broad), integration 
value, coupling constant in Hz if applicable. 
General Procedure A for the Synthesis of 
Oxidative Addition Complexes. A Schlenk 
tube was charged with 
[Pd(COD)(CH2SiMe3)2]15 (200 mg, 0.52 
mmol, 1.0 equiv) and phosphine ligand 
(0.52 mmol, 1.0 equiv), and the solids were 
dissolved in THF (20 mL). 1-Bromo-3,5-
bis(trifluoromethyl)benzene (0.44 mL, 754.0 
mg, 2.58 mmol, 5.0 equiv) was then added 
to the solution and the reaction mixture was 
stirred for 16 h at rt. All the volatiles were 
then removed under vacuum and n-hexanes 
were added. After filtration by cannula transfer under a 
positive pressure of argon, the solid was dried under vacu-
um. Crystallization was achieved using NMR Young tubes 
with CDCl3/n-hexanes or C6D6/n-hexanes solvent mixtures. 
Complex A1. Complex A1 was synthesized according to 
general procedure A using DavePhos L1 (204 mg) as the 
ligand. The title complex was obtained as a grey solid in 
86% yield, and was crystallized in CDCl3/n-hexanes. 1H 
NMR (400 MHz, CDCl3, 293 K) δ 0.95-1.15 (m, 4H), 1.42-
1.62 (m, 6H), 1.64-1.74 (m, 3H), 1.77-1.83 (m, 2H), 1.88-
1.97 (m, 3H), 1.99-2.09 (m, 1H), 2.26-2.35 (m, 1H), 2.59-
2.72 (m, 2H), 3.01 (s, 6H), 6.94-7.03 (m, 2H), 7.07-7.11 
(m, 1H), 7.13-7.17 (m, 1H), 7.31-7.44 (m, 4H), 7.56-7.62 
(m, 1H), 7.64-7.71 (m, 2H). 13C NMR (100.6 MHz, CDCl3, 
293 K) δ 25.4 (CH2), 26.0 (CH2), 26.4 (CH2), 26.9-27.5 (m, 
CH2), 28.9 (d, JCP = 3.6 Hz, CH2), 30.6 (CH2), 35.2 (d, 1JCP 
= 23.9 Hz, CH), 36.3 (d, 1JCP = 29.5 Hz, CH), 44.3 (2CH3), 
117.5 (CH), 118.3 (CH), 120.2 (CH), 123.7 (q, 1JCF = 272.8 
Hz, 2Cq), 125.9 (CH), 127.1 (d, JCP = 5.7 Hz, CH), 128.4 
(d, JCP = 35.0 Hz, Cq), 128.6 (q, 2JCF = 31.7 Hz, 2Cq), 129.5 
(CH), 131.7 (CH), 132.8 (CH), 135.2 (CH), 136.0 (CH), 
138.4 (CH), 141.7 (Cq), 145.5 (Cq), 151.1 (d, JCP = 17.7 Hz, 
Cq), 156.3 (Cq). 31P NMR (121.5 MHz, C6D6, 293 K) δ 
54.0. 19F NMR (282 MHz, C6D6, 293 K) δ –61.7. IR (neat) 
ν 2931, 2855, 1338, 1270, 1120. HRMS (ESI) m/z Calcd 
for C34H39F6NPPd ([M–Br]+) : 712.1767; found: 712.1776.  
Complex A2. Complex A2 was synthesized according to 
general procedure A using 2-(2-(dicyclohexylphosphino)-
1H-imidazol-1-yl)-N,N-dimethylaniline L2 (199 mg) as the 
ligand. After evaporation of THF, n-hexanes were added 
and the reaction mixture was filtered. After evaporation of 
the filtrate, the title complex was obtained as a yellow solid 
in 46% yield, and was crystallized in CDCl3/n-hexanes. 1H 
NMR (400 MHz, C6D6, 293 K) δ 0.75-0.96 (m, 2H), 1.06-
1.16 (m, 4H), 1.20-1.30 (m, 1H), 1.46-1.75 (m, 8H), 1.79-
2.13 (m, 4H), 2.16-2.36 (m, 3H), 2.27 (br s, 6H), 6.49 (br s, 
1H), 6.83-6.91 (m, 1H), 6.93-7.05 (m, 2H), 7.14-7.23 (m, 
3H), 7.48 (s, 1H), 7.72-7.93 (br s, 1H). 13C NMR (100.6 
MHz, C6D6, 293 K) δ 26.4 (4CH2), 27.6 (2CH2), 27.8 
(4CH2), 27.9 (2CH2), 30.6 (br), 31.7 (br), 38.1 (br), 43.9 
(2CH3), 117.3 (CH), 120.3 (CH), 122.5 (CH), 124.6 (q, 1JCF 
Scheme 2. Formation of Malonate Complex B4’ a 
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= 273 Hz, 2Cq), 126.6 (CH), 128.4 (CH), 128.5 (q, 2JCF = 
31.8 Hz, 2Cq), 128.7 (Cq), 130.3 (Cq), 130.9 (CH), 131.0 
(CH), 131.1 (CH), 137.0 (CH), 150.0 (Cq), 152.7 (Cq). 31P 
NMR (121 MHz, C6D6, 293 K) δ 33.8. 19F NMR (282 
MHz, C6D6, 293 K) δ –61.7. IR (neat) ν 2937, 2856, 1340, 
1272, 1121. HRMS (ESI) m/z Calcd for 
C31H37BrF6N3PPdNa ([M+Na]+): 804.0745; found: 
804.0708. 
Complex A3. Complex A3 was synthesized according to 
general procedure A using dicyclohexyl-(2'-
isopropylbiphenyl-2-yl)phosphine L3 (204 mg) as the lig-
and. The title complex was obtained as a yellow solid in 
48% yield, and was crystallized in CDCl3/n-hexanes. 1H 
NMR (400 MHz, C6D6, 323 K) δ 0.93-1.07 (m, 6H), 1.15-
1.33 (m, 6H), 1.37-1.75 (m, 11H), 1.78-2.09 (m, 3H), 2.16-
2.50 (m, 2H), 2.56-2.76 (m, 1H), 6.87-7.05 (m, 3H), 7.06-
7.14 (m, 1H), 7.17-7.38 (m, 4H), 7.44 (s, 1H), 7.67-7.86 
(m, 2H). 13C NMR (100.6 MHz, C6D6, 293 K) δ 23.2 
(CH3), 23.4 (CH3), 25.8 (br, CH2), 26.1-26.4 (br, CH2), 26.4 
(CH), 27.1-27.9 (br, CH2), 30.2-30.6 (br, CH2), 30.4 (d, 1JCP 
= 4.5 Hz, CH), 31.8 (br s, CH2), 32.7-33.4 (br, CH2), 36.8-
38.9 (br, CH), 117.2 (br, CH), 124.5 (q, 1JCF = 272.3 Hz, 
2Cq), 125.8 (CH), 126.5 (CH), 126.7 (br, CH), 128.3 (CH), 
128.5 (q, 2JCF = 33.4 Hz, 2Cq), 129.2 (CH), 129.4 (d, JCP = 
6.4 Hz, CH), 130.7 (d, JCP = 10.9 Hz, CH), 133.8 (CH), 
134.4-135.1 (CH), 137.0 (Cq), 137.1 (CH), 139.9 (Cq), 
144.4 (Cq), 147.0 (Cq), 153.0 (Cq). 31P NMR (202 MHz, 
C6D6, 293 K) δ 44.0. 19F NMR (376 MHz, C6D6, 293 K) δ –
61.8. IR (neat) ν 2934, 2857, 1340, 1273, 1123. HRMS 
(ESI) m/z Calcd for C35H40F6PPd ([M–Br]+):  711.1814; 
found: 711.1798. 
Complex A4. Complex A4 was synthesized according to 
procedure A using CPhos L4 (227 mg) as the ligand. The 
title complex was obtained as a yellow solid in 70% yield, 
and was crystallized in C6D6/n-hexanes. 1H NMR (400 
MHz, CDCl3, 293 K) δ 0.91-1.03 (m, 2H), 1.07-1.31 (m, 
6H), 1.35-1.47 (m, 2H), 1.53-1.63 (m, 2H), 1.63-1.80 (m, 
6H), 2.00-2.09 (m, 2H), 2.13-2.26 (m, 2H), 2.62 (s, 12H), 
6.86-6.92 (m, 2H), 7.08-7.13 (m, 1H), 7.31-7.37 (m, 2H), 
7.43-7.49 (m, 1H), 7.59-7.65 (m, 3H), 7.66-7.71 (m, 1H). 
13C NMR (100.6 MHz, CDCl3, 293 K) δ 25.9 (2CH2), 27.5 
(d, JCP = 10.9 Hz, 2CH2), 27.6 (d, JCP = 11.7 Hz, 2CH2), 
29.4 (2CH2), 30.2 (2CH2), 36.9 (d, 1JCP = 24.3 Hz, 2CH), 
45.1 (4CH3), 112.5 (Cq), 114.9 (2CH), 117.3 (CH), 123.7 
(q, 1JCF = 272.1 Hz, 2Cq), 126.1 (d, JCP = 5.5 Hz, CH), 
127.8 (d, JCP = 25.0 Hz, Cq), 128.6 (q, 2JCF = 31.8 Hz, 2Cq), 
131.3 (CH), 133.5 (Cq), 133.8 (d, JCP = 12.3 Hz, CH), 
134.1 (CH), 135.6 (CH), 136.4 (2CH), 140.8 (Cq), 146.9 (d, 
JCP = 18.6 Hz, Cq), 157.5 (Cq). 31P NMR (162 MHz, CDCl3, 
293 K) δ 33.1. 19F NMR (376 MHz, CDCl3, 293 K) δ –
62.4. IR (neat) ν 2933, 2855, 1339, 1272, 1123. HRMS 
(ESI) m/z Calcd for C36H44F6N2PPd ([M–Br]+): 755.2189; 
found 755.2169.  
Synthesis of Potassium Dimethyl Malonate (5a). Potassi-
um dimethyl malonate was formed by the addition of 1 
equiv of dimethyl malonate to a suspension of 1 equiv of 
KH in THF. The reaction mixture was stirred until no more 
degassing of H2 was observed. Volatiles were removed 
from the resulting solution. The resulting solid was washed 
with n-hexanes and stored in the glovebox at –5°C. 
General Procedure B for the Synthesis of Malonate 
Complexes. A Schlenk flask was charged with potassium 
dimethyl malonate 5a (3.0 equiv) and THF and cooled to 0 
°C. The oxidative addition complex (1.0 equiv) in THF was 
then added at 0 °C. The reaction mixture was stirred for 2 h 
at 0 °C. After removing the volatiles under vacuum, toluene 
was added. The solution was filtered by cannula transfer 
under a positive pressure of argon. The resulting solution 
was concentrated, and precipitation was attempted by the 
addition of n-hexanes. When the product did not precipi-
tate, it was directly crystallized in NMR Young tubes with 
CDCl3/n-hexanes or C6D6/n-hexanes solvent mixtures. 
Complex B1. Complex B1 was synthesized according to 
procedure B from A1 as the oxidative addition complex. 
Crystallization was performed in C6D6/n-hexanes. 1H NMR 
(500 MHz, C6D6, 293 K) δ 0.63-0.72 (m, 1H), 0.85-1.03 
(m, 4H), 1.08-1.19 (m, 1H), 1.22-1.61 (m, 12H), 1.70-1.77 
(m, 1H), 1.80-1.93 (m, 2H), 2.10-2.18 (m, 1H), 2.53 (s, 
6H), 3.17 (s, 3H), 3.23 (s, 3H), 4.91 (s, 1H), 6.85-6.89 (m, 
1H), 6.97-7.04 (m, 2H), 7.06-7.11 (m, 2H), 7.12-7.19 (m, 
3H), 7.65 (s, 1H), 7.92 (s, 2H). 13C NMR (126 MHz, C6D6, 
293 K) δ 26.6 (d, JCP = 1.8 Hz, 2CH2), 27.4 (d, JCP = 9.0 
Hz, CH2), 27.7 (d, JCP = 7.4 Hz, CH2), 28.1 (d, JCP = 13.9 
Hz, CH2), 28.6 (d, JCP = 16.4 Hz, CH2), 30.1 (2CH2), 31.5 
(d, JCP = 5.9 Hz, CH2), 34.0 (CH2), 34.7 (d, 1JCP = 20.3 Hz, 
CH), 39.2 (m, CH), 45.3 (2CH3), 50.7 (CH3), 51.1 (CH3), 
66.7 (CH), 117.3 (m, CH), 119.8 (CH), 121.8 (CH), 124.7 
(q, 1JCF = 273.2 Hz, 2Cq), 126.7 (d, JCP = 41.7 Hz, Cq), 
127.0 (d, JCP = 7.1 Hz, CH), 127.9 (q, 2JCF = 32.3 Hz, 2Cq), 
129.9 (CH), 130.0 (d, JCP = 1.9 Hz, CH), 131.7 (CH), 132.4 
(CH), 135.1 (d, JCP = 8.6 Hz, CH), 135.2 (Cq), 136.6 
(2CH), 146.7 (d, JCP = 10.1 Hz, Cq), 149.9 (d, JCP = 6.7 Hz, 
Cq), 153.6 (Cq), 174.5 (Cq), 174.9 (Cq). 31P NMR (121 
MHz, C6D6, 293 K) δ 53.2. 19F NMR (282 MHz, C6D6, 293 
K) δ –61.9. IR (neat) ν 2941, 1620, 1498, 1342, 1273, 
1120. HRMS (ESI) m/z Calcd for C34H39F6NPPd ([M–
malonate]+): 712.1767; found: 712.1783. 
Complex B2. Complex B2 was synthesized according to 
procedure B from A2 as the oxidative addition complex. 
Crystallization was performed in C6D6/n-hexanes. 1H NMR 
(300 MHz, C6D6, 293 K) δ 0.69-0.84 (m, 2H), 0.88-1.05 
(m, 5H), 1.26-1.37 (m, 3H), 1.39-1.61 (m, 10H), 2.00-2.09 
(m, 2H), 2.36 (s, 6H), 3.19 (s, 3H), 3.26 (s, 3H), 4.86 (s, 
1H), 6.71-6.78 (m, 2H), 6.86-6.90 (m, 1H), 6.98-7.04 (m, 
2H), 7.09-7.13 (m, 1H), 7.65 (br s, 1H), 7.71 (br s, 2H).  
13C-{1H} NMR (100.6 MHz, C6D6, 293 K) δ 25.9-28.5 (m, 
CH2), 30.9 (br, CH2), 37.6 (br, CH), 44.1 (2CH3), 50.8 
(CH3), 51.0 (CH3), 66.7 (CH), 117.4 (m, CH), 120.2 (CH), 
121.5 (CH), 124.6 (q, 1JCF = 272.8 Hz, 2Cq), 127.3 (CH), 
129.5 (d, JCP = 27.5 Hz, Cq), 129.6 (Cq), 130.2 (CH), 130.9 
(d, JCP = 10.2 Hz, CH), 131.2 (CH), 132.5 (q, 2JCF = 33.9 
Hz, 2Cq), 136.3 (2CH), 148.6 (d, JCP = 5.9 Hz, Cq), 151.1 
(Cq), 174.4 (Cq), 174.9 (Cq). 31P NMR (121 MHz, C6D6, 
293 K) δ 30.61. 19F NMR (282 MHz, C6D6, 293 K) δ –61.9. 
IR (neat) ν 2931, 2854, 1620, 1498, 1342, 1273, 1119. 
HRMS (ESI) m/z Calcd for C31H37F6N3PPd ([M–
malonate]+): 702.1670; found: 702.1664. 
  
Complex B3. Complex B3 was synthesized according to 
procedure B from A3 as the oxidative addition complex. 
Crystallization was performed in C6D6/n-hexanes. 1H NMR 
(400 MHz, CDCl3, 293 K) δ 0.77-0.92 (m, 2H), 0.96-1.29 
(m, 5H), 1.07 (d, 3JHH = 6.7 Hz, 3H), 1.19 (d, 3JHH = 6.7 
Hz, 3H), 1.34-1.47 (m, 2H), 1.55-1.91 (m, 10H), 1.98-2.13 
(m, 2H), 2.19-2.31 (m, 1H), 2.71-2.84 (m, 1H), 3.21 (s, 
3H), 3.33 (s, 3H), 4.20 (s, 1H), 7.15-7.21 (m, 1H), 7.28-
7.34 (m, 3H), 7.35-7.44 (m, 5H), 7.47-7.52 (m, 1H), 7.54-
7.63 (m, 1H). 13C NMR (100.6 MHz, CDCl3, 293 K) δ 22.5 
(CH or CH3), 26.2 (d, JCP = 2.6 Hz, CH2), 26.8 (CH or 
CH3), 27.4 (CH2), 27.6 (CH2), 27.7 (CH2), 27.8 (CH2), 27.9 
(CH2), 30.2 (CH2), 30.4 (CH2), 30.6 (CH or CH3), 31.5 (br, 
CH2), 36.0 (d, 1JCP = 23.4 Hz, CH), 51.1 (2CH3), 65.3 
(CH), 117.0 (m, CH), 123.9 (q, 1JCF = 272.8 Hz, 2Cq), 
125.2 (CH), 126.0 (d, JCP = 40.4 Hz, Cq), 126.1 (CH), 
126.8 (d, JCP = 8.3 Hz, CH), 127.9 (q, 2JCF = 32.3 Hz, 2Cq), 
129.1 (CH), 129.5 (d, JCP = 2.2 Hz, CH), 130.3 (CH), 133.3 
(CH), 134.0 (d, JCP = 7.9 Hz, CH), 135.5 (2CH), 139.3 (d, 
JCP = 3.1 Hz, Cq), 145.7 (d, JCP = 8.6 Hz, Cq), 147.1 (Cq), 
148.1 (d, JCP = 5.3 Hz, Cq), 173.9 (Cq), 174.3 (Cq). 31P 
NMR (162 MHz, CDCl3, 293 K) δ 39.9. 19F NMR (376 
MHz, CDCl3, 293 K) δ –62.5. IR (neat) ν 2935, 2361, 
1626, 1502, 1341, 1271, 1129. HRMS (ESI) m/z Calcd for 
C35H40F6PPd ([M–malonate]+): 711.1814; found 711.1785. 
Dimethyl 2-(3,5-bis(trifluoromethyl)phenyl)malonate.16 
Under argon, a flame-dried Schlenk tube was charged with 
CuI (0.05 equiv, 19 mg, 0.1 mmol), 2-phenylphenol (0.1 
equiv, 34 mg, 0.0281 mL, 0.2 mmol), and Cs2CO3 (1.5 
equiv, 977 mg, 3 mmol). Then anhydrous THF (2 mL), 3,5-
bis(trifluoromethyl)iodobenzene (1 equiv, 680 mg, 0.356 
mL, 2 mmol) and dimethyl malonate (2 equiv, 528 mg, 
0.457 mL, 4 mmol) were added. The reaction mixture was 
stirred at 70 °C for 24 h, and then cooled to room tempera-
ture, quenched with a saturated aqueous NH4Cl solution, 
and extracted with ethyl acetate. The organic layer was 
washed with brine and dried over MgSO4. Filtration 
through a plug of Celite® and concentration on a rotary 
evaporator afforded the crude product which was purified 
by silica gel chromatography (elution with cyclohex-
ane/ethyl acetate 4:1). 1H NMR (300 MHz, CDCl3, 293 K) 
δ 3.78 (s, 6H), 4.79 (s, 1H), 7.86 (s, 1H), 7.90 (s, 2H); 13C 
NMR (75 MHz, CDCl3, 293 K) δ 53.4 (2CH3), 56.9 (CH), 
123.2 (q, 1JCF =  272 Hz, 2Cq), 122.6 (CH), 130.0 (2CH), 
132.0 (q, 2JCF = 33 Hz, 2Cq), 135.1 (Cq), 167.4 (2Cq). 19F 
NMR (282 MHz, C6D6, 293 K) δ –62.8; IR (neat) ν 1124, 
1275, 1741, 2959. HRMS (ESI) m/z Calcd for 
C13H10F6NaO4 ([M+Na]+ ): 367.0375; found 367.0368. 
Complex B4’. Complex B4’ was synthesized according to 
procedure B from A4 as the oxidative addition complex. 
During the synthesis, all vessels were kept at 0 °C. Crystal-
lization was performed in C6D6/n-hexanes at 0 °C. For 
characterization purposes, complex B4’ was also synthe-
sized according to procedure B from A4 as the oxidative 
addition complex and the potassium salt of dimethyl 2-(3,5-
bis(trifluoromethyl)phenyl)malonate (5b). 1H NMR (400 
MHz, CDCl3, 293 K) δ 0.64-0.76 (m, 2H), 1.16 (m, 4H), 
1.43-1.56 (m, 4H), 1.59-1.69 (m, 4H), 1.72-1.81 (m, 3H), 
1.97-2.09 (m, 3H), 2.16-2.26 (m, 2H), 2.40 (s, 12H), 3.26 
(s, 6H), 6.88 (m, 2H), 7.24 (m, 1H), 7.39 (br s, 1H), 7.42-
7.47 (m, 1H), 7.48-7.52 (m, 2H), 7.62 (br s, 1H), 7.63 (br s, 
2H), 7.77 (br s, 2H), 7.83 (m, 1H). 13C NMR (100.6 MHz, 
CDCl3, 293 K) δ 26.2 (CH2), 27.5 (CH2), 27.6 (CH2), 27.7 
(CH2), 29.7-30.6 (br, CH2), 31.8 (CH2), 35.6-35.9 (br, CH), 
46.1 (4CH3), 51.5 (2CH3), 80.6 (Cq), 115.4 (2CH), 116.9 
(m, CH), 118.7 (m, CH), 123.9 (q, 1JCF = 272.4 Hz, 2Cq), 
124.0 (q, 1JCF = 272.4 Hz, 2Cq), 126.1 (d, JCP = 9.7 Hz, 
CH), 126.6 (d, JCP = 41.1 Hz, Cq), 127.6 (q, 2JCF = 32.3 Hz, 
2Cq), 128.4 (d, JCP = 2.3 Hz, CH), 129.7 (CH), 130.2 (q, 
2JCF = 32.3 Hz, 2Cq), 131.1 (Cq), 132.7 (2CH), 135.7 (d, JCP 
= 8.8 Hz, CH), 136.5 (2CH), 138.1 (d, JCP = 8.1 Hz, CH), 
140.5 (2Cq), 143.1 (d, JCP = 6.7 Hz, Cq), 146.4 (d, JCP = 6.7 
Hz, Cq), 154.3 (Cq), 170.9 (2Cq). 31P NMR (162 MHz, 
CDCl3, 293 K) δ 49.3. 19F NMR (376 MHz, CDCl3, 293 K) 
δ –62.5, –62.6. IR (neat) ν 2937, 1626, 1346, 1273, 1126. 
HRMS (ESI) m/z Calcd for C49H52F12N2O4PPd ([M–H]+): 
1097.2520; found: 1097.2453. 
X-ray Structural Analyses. Suitable crystals were selected 
and mounted on a Gemini kappa-geometry diffractometer 
(Agilent Technologies UK Ltd) equipped with an Atlas 
CCD detector and using Mo radiation ( l= 0.7107  Å) ex-
cept for B3 where Cu radiation ( l= 1.5418  Å) was used. 
Intensities were collected at 150 K for all compounds but 
B1 (100 K) and A1 (120 K) by means of the CrysalisPro 
software.17 Reflection indexing, unit-cell parameters re-
finement, Lorentz-polarization correction, peak integration 
and background determination were carried out with the 
CrysalisPro software. An analytical absorption correction 
was applied using the modeled faces of the crystal.18 The 
resulting set of hkl was used for structure solution and 
refinement. The structures were solved by direct methods 
with SIR9719 and the least-square refinement on F2 was 
achieved with the CRYSTALS software.20 All non-
hydrogen atoms were refined anisotropically. The hydrogen 
atoms were all located in a difference map, but those at-
tached to carbon atoms were repositioned geometrically. 
The H atoms were initially refined with soft restraints on 
the bond lengths and angles to regularize their geometry 
(C---H in the range 0.93--0.98, N---H in the range 0.86--
0.89 and O---H = 0.82 Å) and Uiso(H) (in the range 1.2-1.5 
times Ueq of the parent atom), after which the positions 
were refined with riding constraints. Complex A3 displayed 
solvent accessible voids of 102 Å3 in the unit-cell were 
residual electronic density was present. The contribution of 
the disordered solvent was removed using the SQUEEZE 
algorithm.21 
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